Tigan (TRIMETHOBENZAMIDE HYDROCHLORIDE)
Tigan (TRIMETHOBENZAMIDE HYDROCHLORIDE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Tigan; Generic name: TRIMETHOBENZAMIDE HYDROCHLORIDE; Manufacturer: Henry Schein, Inc.
| Brand name | Tigan |
|---|---|
| Generic name | TRIMETHOBENZAMIDE HYDROCHLORIDE |
| Manufacturer | Henry Schein, Inc |
| Used for | Indications Tigan ® is indicated for the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis. |
| Dosage | Dosage and Administration (See WARNINGS and PRECAUTIONS .) Dosage should be adjusted according to the indication for therapy, severity of symptoms and the response of the patient. Geriatric Patients Dose adjustment such as reducing the total dose administered at each dosing or increasing the dosing interval should be considered in elderly patients with renal impairment (creatinine clearance ≤ 70 mL/min/1.73m 2 ). Final dose adjustment should be based upon integration of clinical efficacy and saf |
| Warnings | Warnings Tigan ® may produce drowsiness. Patients should not operate motor vehicles or other dangerous machinery until their individual responses have been determined. Usage in Pregnancy: Trimethobenzamide hydrochloride was studied in reproduction experiments in rats and rabbits and no teratogenicity was suggested. The only effects observed were an increased percentage of embryonic resorptions or stillborn pups in rats administered 20 mg and 100 mg/kg and increased resorptions in rabbits receivi |
| Active ingredient(s) | TRIMETHOBENZAMIDE HYDROCHLORIDE |
| Route | INTRAMUSCULAR |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=147def93-cd3d-4e42-89ad-6a6b413bf362 |